Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bridger, Gary J.
85  Ergebnisse:
Personensuche X
?
1

A phase 3 randomized trial of mavorixafor, a CXCR4 antagoni..:

Badolato, Raffaele ; Alsina, Laia ; Azar, Antoine...
Blood.  144 (2024)  1 - p. 35-45 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Design of Substituted Imidazolidinylpiperidinylbenzoic Acid..:

Skerlj, Renato ; Bridger, Gary ; Zhou, Yuanxi...
Journal of Medicinal Chemistry.  56 (2013)  20 - p. 8049-8065 , 2013
Link: https://doi.org/10.1021/..
 
?
3

Plerixafor Plus Granulocyte Colony-Stimulating Factor versu..:

Nademanee, Auayporn P. ; DiPersio, John F. ; Maziarz, Richard T....
Biology of Blood and Marrow Transplantation.  18 (2012)  10 - p. 1564-1572 , 2012
Link: https://doi.org/10.1016/..
 
?
4

The orally bioavailable allosteric CXCR4 HIV-1 entry inhibi..:

Fricker, Simon ; Mosi, Renee ; Anastassova, Virginia...
Retrovirology.  9 (2012)  S1 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
5

Mitigating hERG Inhibition: Design of Orally Bioavailable C..:

Skerlj, Renato ; Bridger, Gary ; Zhou, Yuanxi...
ACS Medicinal Chemistry Letters.  3 (2012)  3 - p. 216-221 , 2012
Link: https://doi.org/10.1021/..
 
?
6

The molecular pharmacology of AMD11070: An orally bioavaila..:

Mosi, Renee M. ; Anastassova, Virginia ; Cox, Jennifer...
Biochemical Pharmacology.  83 (2012)  4 - p. 472-479 , 2012
Link: https://doi.org/10.1016/..
 
?
7

HIV-1 entry inhibition by small-molecule CCR5 antagonists: ..:

Labrecque, Jean ; Metz, Markus ; Lau, Gloria...
Virology.  413 (2011)  2 - p. 231-243 , 2011
Link: https://doi.org/10.1016/..
 
?
8

Design and synthesis of pyridin-2-yloxymethylpiperidin-1-yl..:

Skerlj, Renato ; Bridger, Gary ; Zhou, Yuanxi...
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  8 - p. 2450-2455 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Transplanted CD34+ Cell Dose Is Associated with Long-Term P..:

Stiff, Patrick J. ; Micallef, Ivana ; Nademanee, Auayporn P....
Biology of Blood and Marrow Transplantation.  17 (2011)  8 - p. 1146-1153 , 2011
Link: https://doi.org/10.1016/..
 
?
10

Prospective CCR5 Small Molecule Antagonist Compound Design ..:

Metz, Markus ; Bourque, Elyse ; Labrecque, Jean...
Journal of the American Chemical Society.  133 (2011)  41 - p. 16477-16485 , 2011
Link: https://doi.org/10.1021/..
 
?
11

Practical Convergent Laboratory-Scale Synthesis of a CCR5 R..:

Crawford, Jason B. ; Chen, Gang ; Carpenter, Bryon...
Organic Process Research & Development.  16 (2011)  1 - p. 109-116 , 2011
Link: https://doi.org/10.1021/..
 
?
12

Design of novel CXCR4 antagonists that are potent inhibitor..:

Skerlj, Renato ; Bridger, Gary ; McEachern, Ernest...
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  5 - p. 1414-1418 , 2011
Link: https://doi.org/10.1016/..
 
?
13

Synthesis and SAR of novel CXCR4 antagonists that are poten..:

Skerlj, Renato ; Bridger, Gary ; McEachern, Ernie...
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  1 - p. 262-266 , 2011
Link: https://doi.org/10.1016/..
 
?
14

Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-..:

Skerlj, Renato ; Bridger, Gary ; Zhou, Yuanxi...
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  23 - p. 6950-6954 , 2011
Link: https://doi.org/10.1016/..
 
?
15

CXCR4 in Clinical Hematology:

, In: The Chemokine System in Experimental and Clinical Hematology; Current Topics in Microbiology and Immunology,
Calandra, Gary ; Bridger, Gary ; Fricker, Simon - p. 173-191 , 2010
Link: https://doi.org/10.1007/..
 
1-15